FEASIBILITY AND SAFETY OF ALLOGENEIC EX VIVO ACTIVATED-NK CELL INFUSION AFTER MATCHED RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A PROSPECTIVE PHASE I TRIAL

被引：0
|
作者：
Calmels, B. [1 ]
Devillier, R. [2 ]
Guia, S. [3 ]
Mfarrej, B. [1 ]
Furst, S. [2 ]
Harbi, S. [2 ]
Granata, A. [2 ]
Faucher, C. [2 ]
Izadifar, F. [2 ]
Makni, B. [1 ]
Vicari, O. [1 ]
Lignee, P. [1 ]
Lemarie, C. [1 ]
Fauriat, C. [4 ]
Olive, D. [4 ]
Vivier, E. [3 ]
Chabannon, C. [1 ]
Ugolini, S. [3 ]
Blaise, D. [2 ]
机构：
[1] Inst Paoli Calmettes, Ctr Therapie Cellulaire, Marseille, France
[2] Inst Paoli Calmettes, Unite Transplantat & Therapie Cellulaire, Marseille, France
[3] Ctr Immunol Marseille Luminy, Marseille, France
[4] Inst Paoli Calmettes, Lab Immunomonitoring, Marseille, France
来源：
CYTOTHERAPY | 2017年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
22
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [21] Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial
    de Latour, Regis Peffault
    Chevret, Sylvie
    Ruggeri, Annalisa
    Suarez, Felipe
    Souchet, Laetitia
    Michonneau, David
    de Fontbrune, Flore Sicre
    Coman, Tereza
    t Rubio, Marie
    Nguyen, Stephanie
    Mohty, Mohamad
    Socie, Gerard
    BLOOD, 2016, 128 (22)
  • [22] Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial
    Feng, Yimei
    Wang, Linhui
    Lang, Tao
    Ren, Mingqiang
    Yi, Hai
    Deng, Jianchuan
    Ma, Liangliang
    Xing, Hongyun
    Wang, Dan
    Yao, Han
    Chen, Ting
    Liu, Yuqing
    Zhu, Lidan
    Liu, Jia
    Gao, Shichun
    Gao, Lei
    Zhang, Xi
    BLOOD, 2023, 142
  • [23] Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome
    Jennifer H. Cooperrider
    Noreen Fulton
    Andrew S. Artz
    Richard A. Larson
    Wendy Stock
    Satyajit Kosuri
    Michael Bishop
    Hongtao Liu
    Bone Marrow Transplantation, 2020, 55 : 2204 - 2206
  • [24] Reduced Toxicity Conditioning with Treosulfan and Fludarabine in Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes: Results of an International Prospective Phase II Trial
    Ruutu, Tapani
    Volin, Liisa
    Beelen, Dietrich W.
    Trenschel, Rudolf
    Finke, Juergen
    Schnitzler, Marc
    Holowiecki, Jerzy
    Giebel, Sebastian
    Uharek, Lutz
    Blau, I. Wolfgang
    Stelljes, Matthias
    Kienast, Joachim
    Larsson, Kajsa
    Zander, Axel R.
    Gramatzki, Martin
    Repp, Roland
    Einsele, Hermann
    Stuhler, Gernot
    Freund, Mathias
    Casper, Jochen
    BLOOD, 2008, 112 (11) : 1124 - 1125
  • [25] Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome
    Cooperrider, Jennifer H.
    Fulton, Noreen
    Artz, Andrew S.
    Larson, Richard A.
    Stock, Wendy
    Kosuri, Satyajit
    Bishop, Michael
    Liu, Hongtao
    BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2204 - 2206
  • [26] Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with FLT3-ITD AML
    Chen, Yi-Bin
    Shuli, Li
    Andrew, Lane A.
    Connolly, Christine
    Del Rio, Candice
    Valles, Betsy
    Curtis, Morgan
    Ballen, Karen K.
    Cutler, Corey S.
    Dey, Bimalangshu R.
    El-Jawahri, Areej
    Fathi, Amir T.
    Ho, Vincent T.
    Joyce, Amy
    McAfee, Steven L.
    Rudek, Michelle A.
    Rajkhowa, Trivikram
    Verselis, Sigitas
    Antin, Joseph H.
    Spitzer, Thomas R.
    Levis, Mark
    Soiffer, Robert J.
    BLOOD, 2014, 124 (21)
  • [27] Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial
    Pulewka, Kristin
    Wolff, Daniel
    Herzberg, Philipp Y.
    Greinix, Hildegard
    Heussner, Pia
    Mumm, Friederike H. A.
    von Harsdorf, Stephanie
    Rieger, Kathrin
    Hemmati, Philipp
    Hochhaus, Andreas
    Hilgendorf, Inken
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (08) : 1613 - 1619
  • [28] Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial
    Kristin Pulewka
    Daniel Wolff
    Philipp Y. Herzberg
    Hildegard Greinix
    Pia Heussner
    Friederike H. A. Mumm
    Stephanie von Harsdorf
    Kathrin Rieger
    Philipp Hemmati
    Andreas Hochhaus
    Inken Hilgendorf
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1613 - 1619
  • [29] Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies
    Luo, Yun
    Zeng, Han-Qing
    Shen, Yan
    Zhang, Ping
    Lou, Shi-Feng
    Chen, Lin
    Deng, Jian-Chuan
    LEUKEMIA RESEARCH, 2016, 48 : 6 - 10
  • [30] Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
    Xu, Ziheng
    Choi, Jaebok
    Cooper, Matthew
    King, Jeffrey
    Fiala, Mark A.
    Liu, Jingxia
    Pusic, Iskra
    Romee, Rizwan
    Cashen, Amanda
    Jacoby, Meagan A.
    Stockerl-Goldstein, Keith
    Abboud, Camille
    Vij, Ravi
    Uy, Geoffrey
    Westervelt, Peter
    Walter, Matthew J.
    Dipersio, John F.
    Schroeder, Mark A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 699.e1 - 699.e9
12345